We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Dr Malcolm Rhodes to be Awarded Peter Dunhill Award

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Dr Malcolm Rhodes to be Awarded Peter Dunhill Award"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

The BioIndustry Association (BIA) congratulates Dr Malcolm Rhodes, for being selected as the recipient for the annual Peter Dunhill Award for Outstanding Contribution to UK Bioprocessing.

Dr Malcolm Rhodes, Biotechnology and Biological Science Research Council (BBSRC) Industrial Impact Fellow at the University of Manchester, will be presented the award and will give the Peter Dunhill Award lecture at the annual bioProcessUK conference. The theme for this year’s conference which is taking place in Liverpool on 25-26 November is “An Integrated Approach to Biologics Manufacturing”.

Malcolm started his career at Pfizer working on the genetics of Streptomyces and the improvement of antibiotic production and biotransformations for the production of high value organic compounds. He then moved to the emerging biotechnology industry, at Celltech (now Lonza Biologics and UCB) where he worked as Head of Process R&D on the production of recombinant proteins and monoclonal antibodies, protein recovery and purification and analysis, developing over 30 proteins for clinical trials.

He worked as R&D Director for a small industrial biotech and then Bioscot (now part of Merck Millipore) where he directed a project to trial anti-Rh(D) monoclonal antibodies for haemolytic disease of newborns, produced diagnostic reagents for blood typing and was responsible for manufacturing operations. After that he joined Serologicals Corporation in the USA as Head of Global R&D. Malcolm returned to the UK as Technical Director of bioProcessUK (which became the HealthTech and Medicines Knowledge Transfer Network) and has been pivotal in engaging industry with the proposed Bioprocessing Research Industry Club (BRIC) programme, becoming the industrial co-ordinator of the Club, working to promote research into biopharmaceuticals. Dr Malcolm Rhodes’ current role as BBSRC Industrial Impact Fellow, is to help build collaborations between industry and academia.

Steve Bates, Chief Executive Office of BIA, said: “Malcolm’s commitment, skill and passion for bioprocessing are widely recognized across the industry and we are delighted that this is being acknowledged with this prestigious award. Malcolm has been a significant catalyst in the industry over the past decades as well as mentoring and assisting numerous emerging companies and professionals. It is thanks to the exceptional work and talent of individuals like Malcolm, that the UK is fast becoming a leading global location for bioprocessing and medicines manufacturing.”

Dr Rhodes commented: “I am extremely honoured to have been awarded the Peter Dunnill Award. Prof Dunnill and the previous recipients of this award have contributed so much to our field, and it is a real privilege to be associated with them. I would also like to thank my colleagues from industry and academia for awarding this great honour to me."